Pyroptosis in Periprosthetic Osteolysis.


Journal

Biomolecules
ISSN: 2218-273X
Titre abrégé: Biomolecules
Pays: Switzerland
ID NLM: 101596414

Informations de publication

Date de publication:
23 11 2022
Historique:
received: 02 10 2022
revised: 12 11 2022
accepted: 18 11 2022
entrez: 23 12 2022
pubmed: 24 12 2022
medline: 27 12 2022
Statut: epublish

Résumé

Periprosthetic osteolysis (PPO) along with aseptic loosening (AL) caused by wear particles after artificial joint replacement is the key factor in surgical failure and subsequent revision surgery, however, the precise molecular mechanism underlying PPO remains unclear. Aseptic inflammation triggered by metal particles, resulting in the imbalance between bone formation by osteoblasts and bone resorption by osteoclasts may be the decisive factor. Pyroptosis is a new pro-inflammatory pattern of regulated cell death (RCD), mainly mediated by gasdermins (GSDMs) family, among which GSDMD is the best characterized. Recent evidence indicates that activation of NLRP3 inflammasomes and pyroptosis play a pivotal role in the pathological process of PPO. Here, we review the pathological process of PPO, the molecular mechanism of pyroptosis and the interventions to inhibit the inflammation and pyroptosis of different cells during the PPO. Conclusively, this review provides theoretical support for the search for new strategies and new targets for the treatment of PPO by inhibiting pyroptosis and inflammation.

Identifiants

pubmed: 36551161
pii: biom12121733
doi: 10.3390/biom12121733
pmc: PMC9775904
pii:
doi:

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : National Natural Science Foundation of China
ID : 81871795

Références

Clin Exp Immunol. 2014 Sep;177(3):586-97
pubmed: 24749816
Nature. 2016 Jul 06;535(7610):153-8
pubmed: 27383986
Front Immunol. 2013 Oct 16;4:333
pubmed: 24137163
J Arthroplasty. 2014 Sep;29(9):1774-8
pubmed: 25007726
Transl Stroke Res. 2022 Oct 7;:
pubmed: 36205878
Trends Microbiol. 2001 Mar;9(3):113-4
pubmed: 11303500
Nature. 2003 May 15;423(6937):337-42
pubmed: 12748652
Ann Rheum Dis. 2018 Oct;77(10):1490-1497
pubmed: 29959183
Mol Med Rep. 2018 Apr;17(4):5463-5469
pubmed: 29393464
J Arthroplasty. 2017 Sep;32(9):2663-2668
pubmed: 28456561
Front Immunol. 2021 May 17;12:657687
pubmed: 34079546
BMC Biochem. 2007 Nov 22;8 Suppl 1:S6
pubmed: 18047743
Biomaterials. 2017 Feb;117:1-9
pubmed: 27918885
Neurocrit Care. 2017 Aug;27(1):44-50
pubmed: 28181102
Immunol Rev. 2022 Oct;311(1):130-150
pubmed: 35524757
Acta Pharm Sin B. 2020 Mar;10(3):462-474
pubmed: 32140392
Nat Rev Immunol. 2020 Mar;20(3):143-157
pubmed: 31690840
J Bone Joint Surg Am. 2018 Feb 7;100(3):189-196
pubmed: 29406339
Clin Transl Med. 2020 Dec;10(8):e240
pubmed: 33377656
J Nanobiotechnology. 2021 Jun 6;19(1):170
pubmed: 34092246
Science. 2021 Jun 25;372(6549):
pubmed: 35058659
Int Orthop. 2016 Jul;40(7):1545-52
pubmed: 26498175
Sci Rep. 2020 May 8;10(1):7823
pubmed: 32385413
Toxicol Appl Pharmacol. 2020 Dec 15;409:115309
pubmed: 33130049
Neurol Clin. 2022 Nov;40(4):785-797
pubmed: 36270691
Front Immunol. 2022 Apr 28;13:843520
pubmed: 35572519
Acta Biomater. 2022 Apr 1;142:345-360
pubmed: 35151924
Front Pharmacol. 2022 Sep 29;13:939929
pubmed: 36249770
Curr Drug Targets Inflamm Allergy. 2005 Jun;4(3):325-8
pubmed: 16101541
Front Cell Dev Biol. 2022 Feb 02;10:821225
pubmed: 35186932
ACS Nano. 2022 Mar 22;16(3):4102-4115
pubmed: 35262333
Br J Rheumatol. 1995 Dec;34(12):1127-34
pubmed: 8608353
Int Immunopharmacol. 2022 Nov;112:109278
pubmed: 36215870
Materials (Basel). 2020 Aug 17;13(16):
pubmed: 32824426
Proc Natl Acad Sci U S A. 2018 Jun 26;115(26):6792-6797
pubmed: 29891674
Aging (Albany NY). 2020 Jun 11;12(12):11698-11716
pubmed: 32527985
J Cell Physiol. 2020 Apr;235(4):4001-4010
pubmed: 31643094
Acta Biomater. 2015 Sep;24:352-60
pubmed: 26112372
Acta Biomater. 2013 Sep;9(9):8046-58
pubmed: 23669623
J Exp Med. 2021 May 3;218(5):
pubmed: 33835145
Immunology. 2018 Jun;154(2):186-195
pubmed: 29455468
Signal Transduct Target Ther. 2022 Aug 13;7(1):286
pubmed: 35963853
Biomaterials. 2013 Apr;34(11):2611-23
pubmed: 23347837
Front Endocrinol (Lausanne). 2022 Oct 20;13:972890
pubmed: 36339405
Cell Death Dis. 2019 Feb 12;10(2):128
pubmed: 30755589
J Immunol. 2014 Feb 15;192(4):1835-46
pubmed: 24453255
Cytotherapy. 2020 Aug;22(8):412-423
pubmed: 32561161
Nutrients. 2022 Sep 17;14(18):
pubmed: 36145228
J Am Acad Orthop Surg. 2008;16 Suppl 1:S42-8
pubmed: 18612013
J Bone Joint Surg Br. 2012 May;94(5):619-23
pubmed: 22529080
Bioact Mater. 2021 Mar 18;6(10):3343-3357
pubmed: 33817415
JBJS Rev. 2016 Jul 5;4(7):
pubmed: 27509327
Arthritis Res Ther. 2007;9 Suppl 1:S1
pubmed: 17634140
Nat Med. 2015 Mar;21(3):248-55
pubmed: 25686105
J Immunol. 2022 May 1;208(9):2184-2195
pubmed: 35418465
J Clin Med. 2019 Dec 01;8(12):
pubmed: 31805704
Trends Cell Biol. 2017 Sep;27(9):673-684
pubmed: 28619472
Immunity. 2013 Jun 27;38(6):1142-53
pubmed: 23809161
Redox Biol. 2020 Jan;28:101309
pubmed: 31487581
Curr Pharm Des. 2007;13(4):367-85
pubmed: 17311555
Proc Natl Acad Sci U S A. 2018 Jun 26;115(26):E6065-E6074
pubmed: 29895691
J Pineal Res. 2019 Oct;67(3):e12594
pubmed: 31286565
J Orthop Res. 2015 Jul;33(7):1103-10
pubmed: 25764495
Adv Mater. 2022 Apr;34(15):e2106723
pubmed: 35143076
Biomaterials. 2012 Jun;33(17):4251-63
pubmed: 22436801
Nat Commun. 2018 Apr 19;9(1):1560
pubmed: 29674674
Nat Med. 2013 Jan;19(1):57-64
pubmed: 23202296
Osteoporos Int. 2014 Dec;25(12):2685-700
pubmed: 25030653
Bone Res. 2022 Sep 20;10(1):60
pubmed: 36127328
Structure. 2018 May 1;26(5):778-784.e3
pubmed: 29576317
Front Mol Biosci. 2021 Jun 23;8:666295
pubmed: 34250013
Nat Med. 2011 Oct 23;17(11):1473-80
pubmed: 22019888
Int Immunopharmacol. 2021 May;94:107459
pubmed: 33611061
Bone Res. 2016 Nov 29;4:16035
pubmed: 27990310
Pharmacol Res. 2022 Oct;184:106400
pubmed: 35988868
J Inflamm Res. 2022 Aug 08;15:4537-4545
pubmed: 35966002
Redox Biol. 2020 Jan;28:101334
pubmed: 31606551
Orthopedics. 2008 Jun;31(6):518, 615-8
pubmed: 18661872
J Transl Med. 2016 Jul 07;14(1):205
pubmed: 27387445
Cancer Cell. 2013 Oct 14;24(4):542-56
pubmed: 24135284
Sci Rep. 2019 Jul 18;9(1):10429
pubmed: 31320680
Biochim Biophys Acta Mol Cell Res. 2019 Jan;1866(1):114-123
pubmed: 30026076
Basic Res Cardiol. 2022 Aug 23;117(1):40
pubmed: 35997820
J Bone Joint Surg Am. 2007 Apr;89(4):780-5
pubmed: 17403800
Acta Biomater. 2020 May;108:347-357
pubmed: 32194260
Biomaterials. 2007 Dec;28(34):5044-8
pubmed: 17645943
Cell Host Microbe. 2013 Jun 12;13(6):759-72
pubmed: 23768499
Biochem Pharmacol. 2020 Jan;171:113715
pubmed: 31751538
Nat Commun. 2015 Jun 10;6:7360
pubmed: 26059659
Mil Med Res. 2022 Aug 23;9(1):46
pubmed: 35996168
Int Immunopharmacol. 2022 Jun;107:108699
pubmed: 35305384
J Bone Joint Surg Am. 2002 Mar;84(3):411-9
pubmed: 11886911
J Biol Chem. 1986 Jun 5;261(16):7123-6
pubmed: 3711080
J Bone Miner Res. 2009 Oct;24(10):1753-62
pubmed: 19419302
J Neuroinflammation. 2020 Sep 21;17(1):280
pubmed: 32958021
Nutrients. 2022 Aug 31;14(17):
pubmed: 36079867
Theranostics. 2021 Feb 15;11(8):3981-3995
pubmed: 33664876
Oncol Rep. 2013 Aug;30(2):723-30
pubmed: 23708264
Nature. 2022 May;605(7910):527-531
pubmed: 35545676
Clin Orthop Relat Res. 2007 Jul;460:240-52
pubmed: 17620815
Nature. 2021 Mar;591(7848):131-136
pubmed: 33472215
J Mater Sci Mater Med. 2002 Nov;13(11):1001-5
pubmed: 15348168
Cell. 2014 May 22;157(5):1013-22
pubmed: 24855941
Nature. 2015 Oct 29;526(7575):660-5
pubmed: 26375003
Mol Cancer. 2013 Apr 23;12:30
pubmed: 23617834
Proc Natl Acad Sci U S A. 2018 Feb 13;115(7):E1530-E1539
pubmed: 29378952
Signal Transduct Target Ther. 2022 Apr 22;7(1):127
pubmed: 35459858
Theranostics. 2019 Jul 3;9(16):4648-4662
pubmed: 31367247
Metab Brain Dis. 2020 Jun;35(5):809-818
pubmed: 32185593
Nat Commun. 2016 Feb 03;7:10572
pubmed: 26838040
J Mater Sci Mater Med. 2003 Sep;14(9):731-8
pubmed: 15348391
Nat Microbiol. 2019 Apr;4(4):701-713
pubmed: 30804548
Orthop Traumatol Surg Res. 2021 Feb;107(1):102744
pubmed: 33316444
Int J Occup Med Environ Health. 2012 Sep;25(4):463-9
pubmed: 23212287
Clin Rheumatol. 2018 Nov;37(11):3057-3062
pubmed: 30291470
Mol Cancer. 2014 Jan 07;13:5
pubmed: 24393203
Cell Death Differ. 2018 Mar;25(3):486-541
pubmed: 29362479
Curr Top Med Chem. 2005;5(16):1697-717
pubmed: 16375749
Mol Cell. 2021 Apr 1;81(7):1370-1371
pubmed: 33798414
Nutrients. 2022 Aug 30;14(17):
pubmed: 36079829
J Nanobiotechnology. 2022 Mar 9;20(1):120
pubmed: 35264201
J Bone Joint Surg Am. 2019 Mar 6;101(5):466-472
pubmed: 30845042
BMC Musculoskelet Disord. 2022 Apr 9;23(1):340
pubmed: 35397519
Proc Natl Acad Sci U S A. 2022 Jan 11;119(2):
pubmed: 34996874
J Neurosci Res. 2019 Jun;97(6):645-660
pubmed: 30600840
J Biol Chem. 2003 Feb 14;278(7):5001-8
pubmed: 12460992
J Biomed Mater Res A. 2021 Jun;109(6):994-1003
pubmed: 32803914
J Bone Miner Metab. 2021 Jan;39(1):19-26
pubmed: 33079279
Int Immunopharmacol. 2022 Sep;110:109072
pubmed: 35978515
J Biomed Mater Res A. 2017 Mar;105(3):912-926
pubmed: 28076890
Front Cell Dev Biol. 2020 Mar 31;8:167
pubmed: 32328491

Auteurs

Jian Yin (J)

Department of Orthopedics, Shanghai General Hospital of Nanjing Medical University, Shanghai 201600, China.
Department of Orthopedics, The Affiliated Jiangning Hospital with Nanjing Medical University, Nanjing 211100, China.

Zhaoyang Yin (Z)

Department of Orthopedics, The Affiliated Lianyungang Hospital of Xuzhou Medical University (The First People's Hospital of Lianyungang), Lianyungang 222000, China.

Peng Lai (P)

Department of Orthopedics, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 201600, China.

Xinhui Liu (X)

Department of Orthopedics, The Affiliated Jiangning Hospital with Nanjing Medical University, Nanjing 211100, China.

Jinzhong Ma (J)

Department of Orthopedics, Shanghai General Hospital of Nanjing Medical University, Shanghai 201600, China.
Department of Orthopedics, The Affiliated Jiangning Hospital with Nanjing Medical University, Nanjing 211100, China.
Department of Orthopedics, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 201600, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH